Chennai-based Trivitron acquires ETA Star Healthcare

PTI : Dubai, Wed Jan 30 2013, 13:22 hrs

Ads by Google

Top Stories

Medical equipment maker Trivitron Healthcare has announced reinforced foray into the Middle East market by converting an existing joint venture with ETA Star Healthcare into a wholly-owned subsidiary in Dubai.

The JV with the Al Ghurarir Group company was established in 2006 and in the end of 2012 Trivitron acquired it completely setting up its own offices in Dubai Healthcare City to pursue an aggressive growth mandate for its innovative, indigenously manufactured products in the USD 80 billion Middle East market, the company said here on Tuesday.

Participating at the ongoing Arab Health 2013, Trivitron said that as part of its strategic global growth plan, the company has also made a 100 per cent acquisition of the globally renowned Finland-based Anilabsyatem.

The acquisition will also help bring Anilabsystem's product into the Middle East market, African and emerging markets apart from Trivitron¿s indigenously manufactured, innovative products in critical care and operating room solutions, lab diagnostics (IVD) and X-ray imaging solutions, it said.

MD and Founder of Trivitron Healthcare G S K Velu said: "We are glad to enter the emerging markets of the world with our own branded products and solutions. This forum has helped us in establishing our self as globally acclaimed fully integrated medical technology company, focused on innovation, manufacturing, technical service support, patient healthcare delivery and skill education.

Headquartered in Chennai, Trivitron group's products are exported to over 160 countries including advanced markets like the US, Europe and Japan.

Trivitron has three internationally accredited and world-class manufacturing facilities in Chennai/ Mumbai and Pune, producing a range of imaging diagnostics products

including ultrasound and color doppler machines, X Ray equipments.

Ads by Google

ALSO READ

Now, 15-year-old girls can buy morning after emergency contraceptive pills in US

US govt sues Novartis for health care fraud

US govt sues Novartis Pharmaceuticals for health care fraud

'New norms won't lead to rise in drug prices for a year'

The product is generic version of Novartis AG's Reclast injection in the same strength. (Reuters)

Dr Reddy's launches generic Zoledronic Acid injection in US

Please read our terms of use before posting comments

TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).